300288.SZ
朗玛信息
SZSE · Healthcare · I 信息技术 · CN
CNY 9.71
−1.22%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 290.6M | 298.1M | 379.1M | 459.6M | 436.6M |
| Cost of Revenue | 215.3M | 207.6M | 252.7M | 280.3M | 271.8M |
| Gross Profit | 75.4M | 90.5M | 126.3M | 179.3M | 164.9M |
| Operating Expenses | |||||
| R&D Expense | 21.9M | 23.0M | 31.6M | 33.9M | 28.6M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 54.3M | 54.6M | 58.5M | 56.7M | 63.4M |
| Selling & Marketing Expense | 23.8M | 24.7M | 7.3M | 8.7M | 12.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 103.8M | 105.6M | 99.3M | 112.7M | 106.4M |
| Cost and Expenses | 319.1M | 313.1M | 352.0M | 393.0M | 378.1M |
| Operating Income (EBIT) | (6.8M) | 7.0M | (506.5M) | 90.2M | 81.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (7.8M) | 6.1M | (506.2M) | 90.0M | 80.1M |
| Income Tax Expense | (646.6K) | 382.1K | 4.5M | 11.7M | 12.6M |
| Bottom Line | |||||
| Net Income | (1.3M) | 9.3M | (512.1M) | 77.5M | 70.3M |
| Earnings from Cont. Ops | (7.1M) | 5.7M | (510.7M) | 78.3M | 67.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (1.3M) | 9.3M | (512.1M) | 77.5M | 70.3M |
| Per Share | |||||
| Basic EPS | (CN¥0.01) | CN¥0.03 | (CN¥1.52) | CN¥0.23 | CN¥0.21 |
| Diluted EPS | (CN¥0.01) | CN¥0.03 | (CN¥1.52) | CN¥0.23 | CN¥0.21 |
| Revenue Per Share | CN¥0.86 | CN¥0.96 | CN¥1.13 | CN¥1.36 | CN¥1.30 |
| Shares | |||||
| Basic Shares Outstanding | 338.8M | 311.4M | 336.9M | 336.8M | 334.7M |
| Diluted Shares Outstanding | 338.8M | 311.4M | 336.9M | 336.8M | 334.7M |
| Profitability Metrics | |||||
| EBITDA | — | 32.5M | (486.1M) | 108.1M | 101.4M |
| D&A | — | 25.5M | 20.4M | 17.9M | 20.0M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026